New online tool aims to clear up confusion around cancer screening

NCT ID NCT05512260

Terminated Knowledge-focused Sponsor: Karolinska Institutet Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aimed to create a web-based decision aid for people invited to cancer screening in Sweden. The tool would provide clear information about the benefits and harms of screening, helping individuals decide based on knowledge rather than fear. The study was withdrawn before it started, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Individual decision aid (iDA) - a web-based tool
What this could lead to: If successful, this could help people make more informed, personal decisions about cancer screening, potentially increasing participation and reducing fear or misconceptions.
What could go wrong: The study was withdrawn before enrolling any participants, so no data was collected. The tool may not work as intended or may not reach the groups that need it most.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOPLASM, BREAST are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast neoplasm colorectal neoplasm ovarian cancer ovarian neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEOPLASM, BREAST NEOPLASM, COLORECTAL NEOPLASM, OVARIAN

Contacts and locations

Show contact details

Locations

Karolinska Institutet

Huddinge, 14152, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.